{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:23:17Z","timestamp":1772608997542,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001756"],"award-info":[{"award-number":["82001756"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82041038"],"award-info":[{"award-number":["82041038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2020YFC0842600"],"award-info":[{"award-number":["2020YFC0842600"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.vaccine.2022.09.057","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T02:12:52Z","timestamp":1664158372000},"page":"6839-6848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation"],"prefix":"10.1016","volume":"40","author":[{"given":"Tingting","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gege","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhe","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanlin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianjiao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junping","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinghui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangquan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingbing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinjian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2022.09.057_b0005","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cmi.2020.03.026","article-title":"COVID-19, SARS and MERS: are they closely related?","volume":"26","author":"Petrosillo","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.057_b0010","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202187","article-title":"Mapping and role of T cell response in SARS-CoV-2-infected mice","volume":"218","author":"Zhuang","year":"2021","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.057_b0015","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.cell.2021.03.036","article-title":"SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies","volume":"184","author":"Hoffmann","year":"2021","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.057_b0020","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.cell.2021.02.042","article-title":"SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape","volume":"184","author":"Li","year":"2021","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.vaccine.2022.09.057_b0025","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.057_b0030","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.057_b0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41591-021-01255-3","article-title":"Sixteen novel lineages of SARS-CoV-2 in South Africa","volume":"27","author":"Tegally","year":"2021","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.vaccine.2022.09.057_b0040","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant","volume":"385","author":"Lopez Bernal","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2022.09.057_b0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc2104974","article-title":"Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants","volume":"385","author":"Abu-Raddad","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.09.057_b0050","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2022.09.057_b0055","doi-asserted-by":"crossref","unstructured":"S. Cele, L. Jackson, D.S. Khoury, et al., Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization, Nature (2021).","DOI":"10.1038\/s41586-021-04387-1"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.057_b0060","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","article-title":"A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS","volume":"182","author":"Dai","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.vaccine.2022.09.057_b0065","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"6485","key":"10.1016\/j.vaccine.2022.09.057_b0070","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.vaccine.2022.09.057_b0075","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1007\/s00018-004-4242-5","article-title":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus","volume":"61","author":"Kuhn","year":"2004","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"10.1016\/j.vaccine.2022.09.057_b0080","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/423286","article-title":"Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection","volume":"190","author":"Yuchun","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.057_b0085","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.chest.2020.03.039","article-title":"Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection","volume":"158","author":"Zhang","year":"2020","journal-title":"Chest"},{"issue":"20","key":"10.1016\/j.vaccine.2022.09.057_b0090","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.09.057_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2021.112971","article-title":"Functionalized terahertz plasmonic metasensors: femtomolar-level detection of SARS-CoV-2 spike proteins","volume":"177","author":"Ahmadivand","year":"2021","journal-title":"Biosens Bioelectron"},{"issue":"16","key":"10.1016\/j.vaccine.2022.09.057_b0100","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.057_b0105","doi-asserted-by":"crossref","first-page":"eaav4580","DOI":"10.1126\/sciadv.aav4580","article-title":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Sci Adv"},{"issue":"7592","key":"10.1016\/j.vaccine.2022.09.057_b0110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature17200","article-title":"Pre-fusion structure of a human coronavirus spike protein","volume":"531","author":"Kirchdoerfer","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2022.09.057_b0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.057_b0120","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.057_b0125","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1080\/22221751.2020.1781551","article-title":"Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site","volume":"9","author":"Jin","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"6501","key":"10.1016\/j.vaccine.2022.09.057_b0130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"issue":"6166","key":"10.1016\/j.vaccine.2022.09.057_b0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1126\/science.1235681","article-title":"Emerging principles for the therapeutic exploitation of glycosylation","volume":"343","author":"Dalziel","year":"2014","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.vaccine.2022.09.057_b0140","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/glycob\/cwy021","article-title":"Global aspects of viral glycosylation","volume":"28","author":"Bagdonaite","year":"2018","journal-title":"Glycobiology"},{"issue":"7","key":"10.1016\/j.vaccine.2022.09.057_b0145","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nsmb.2594","article-title":"Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120","volume":"20","author":"Kong","year":"2013","journal-title":"Nat Struct Mol Biol"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.057_b0150","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02428-16","article-title":"Glycosylation benchmark profile for HIV-1 envelope glycoprotein production based on eleven env trimers","volume":"91","author":"Go","year":"2017","journal-title":"J Virol"},{"issue":"7815","key":"10.1016\/j.vaccine.2022.09.057_b0155","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.057_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006614","article-title":"Targeted N-glycan deletion at the receptor-binding site retains HIV Env NFL trimer integrity and accelerates the elicited antibody response","volume":"13","author":"Dubrovskaya","year":"2017","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.057_b0165","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.celrep.2016.04.078","article-title":"High-density array of well-ordered HIV-1 spikes on synthetic liposomal nanoparticles efficiently activate B cells","volume":"15","author":"Ingale","year":"2016","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2022.09.057_b0170","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.immuni.2019.10.008","article-title":"Vaccination with glycan-modified HIV NFL envelope trimer-liposomes elicits broadly neutralizing antibodies to multiple sites of vulnerability","volume":"51","author":"Dubrovskaya","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2022.09.057_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2020.12.011","article-title":"COVID-19 vaccines: the status and perspectives in delivery points of view","volume":"170","author":"Chung","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.057_b0180","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1080\/22221751.2020.1821583","article-title":"SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates","volume":"9","author":"Li","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.057_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"Sanders","year":"2013","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.057_b0190","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1080\/22221751.2020.1815589","article-title":"Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"7798","key":"10.1016\/j.vaccine.2022.09.057_b0195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.vaccine.2022.09.057_b0200","doi-asserted-by":"crossref","first-page":"13419","DOI":"10.1073\/pnas.212519299","article-title":"Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line","volume":"99","author":"Reeves","year":"2002","journal-title":"PNAS"},{"issue":"7","key":"10.1016\/j.vaccine.2022.09.057_b0205","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1021\/bi00338a028","article-title":"Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase F","volume":"24","author":"Tarentino","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2022.09.057_b0210","doi-asserted-by":"crossref","unstructured":"Stanley P., Chaney W. Control of carbohydrate processing the leclA CHO mutation results in partial loss of N-acetylglucosaminyltransferase I activity. Mol Cell Biol 1985;5(6):1204\u201311.","DOI":"10.1128\/MCB.5.6.1204"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.057_b0215","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/glycob\/cwt161","article-title":"A novel baculovirus vector for the production of nonfucosylated recombinant glycoproteins in insect cells","volume":"24","author":"Mabashi-Asazuma","year":"2014","journal-title":"Glycobiology"},{"issue":"2","key":"10.1016\/j.vaccine.2022.09.057_b0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/glycob\/cws143","article-title":"Impact of a human CMP-sialic acid transporter on recombinant glycoprotein sialylation in glycoengineered insect cells","volume":"23","author":"Mabashi-Asazuma","year":"2013","journal-title":"Glycobiology"},{"issue":"10","key":"10.1016\/j.vaccine.2022.09.057_b0225","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2174\/138945007782151360","article-title":"Protein N-glycosylation in the baculovirus-insect cell system","volume":"8","author":"Shi","year":"2007","journal-title":"Curr Drug Targets"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.057_b0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0042-6822(03)00120-X","article-title":"Developing baculovirus-insect cell expression systems for humanized recombinant glycoprotein production","volume":"310","author":"Jarvis","year":"2003","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.057_b0235","doi-asserted-by":"crossref","first-page":"15031","DOI":"10.1038\/s41598-018-33390-2","article-title":"Structural rearrangements maintain the glycan shield of an HIV-1 envelope trimer after the loss of a glycan","volume":"8","author":"Ferreira","year":"2018","journal-title":"Sci Rep"},{"issue":"7830","key":"10.1016\/j.vaccine.2022.09.057_b0240","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","article-title":"A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity","volume":"586","author":"Yang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2022.09.057_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2022.102348","article-title":"Glycosylation as a key parameter in the design of nucleic acid vaccines","volume":"73","author":"Ozdilek","year":"2022","journal-title":"Curr Opin Struct Biol"},{"issue":"7","key":"10.1016\/j.vaccine.2022.09.057_b0250","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrm3383","article-title":"Vertebrate protein glycosylation: diversity, synthesis and function","volume":"13","author":"Moremen","year":"2012","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:21:39Z","timestamp":1759404099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22011665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":50,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0264410X22011665"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}